Sexual dimorphism of NAFLD in adults. Focus on clinical aspects and implications for practice and translational research
A Lonardo, A Suzuki - Journal of clinical medicine, 2020 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) embraces the clinico-pathological consequences
of hepatic lipotoxicity and is a major public health problem globally. Sexual dimorphism is a …
of hepatic lipotoxicity and is a major public health problem globally. Sexual dimorphism is a …
In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome
DSH Bell, T Jerkins - Diabetes, Obesity and Metabolism, 2023 - Wiley Online Library
Pioglitazone improves glycaemic control, not only by lowering insulin resistance, but also by
improving beta cell function. Because of the improved beta cell function the glycaemic …
improving beta cell function. Because of the improved beta cell function the glycaemic …
The role of vitamin deficiency in liver disease: To supplement or not supplement?
Over the past few years, growing interest has been shown for the impact of dietary
requirements and nutritional factors on chronic diseases. As a result, nutritional programs …
requirements and nutritional factors on chronic diseases. As a result, nutritional programs …
Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial
A Anushiravani, N Haddadi… - European journal of …, 2019 - journals.lww.com
Materials and methods We conducted a randomized double-blinded, placebo-controlled trial
on 150 consecutive patients with NAFLD who were assigned to five groups: lifestyle plus …
on 150 consecutive patients with NAFLD who were assigned to five groups: lifestyle plus …
[HTML][HTML] Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
Hepatocellular carcinoma (HCC) is the most common type of liver cancer worldwide. Viral
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
Cost-effective analysis of hepatitis A vaccination in Kerala state, India
YK Gurav, BS Bagepally, N Chitpim, A Sobhonslidsuk… - Plos one, 2024 - journals.plos.org
Several hepatitis A outbreaks have recently been reported in Kerala state, India. To inform
coverage decision of hepatitis A vaccine in Kerala, this study aimed to examine the cost …
coverage decision of hepatitis A vaccine in Kerala, this study aimed to examine the cost …
Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome
Background & aims A growing proportion of children with short bowel syndrome (SBS)
remain dependent on long-term parenteral nutrition (PN). Teduglutide offers the potential for …
remain dependent on long-term parenteral nutrition (PN). Teduglutide offers the potential for …
Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease
Background Nonalcoholic fatty liver disease (NAFLD) is associated with substantial
morbidity, mortality, and economic burden. With currently no approved treatment, an …
morbidity, mortality, and economic burden. With currently no approved treatment, an …
Nonalcoholic fatty liver disease in asia, Africa, and Middle East region
Nonalcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic hepatic
disease worldwide. 1 It consists of a histopathological spectrum that encompasses …
disease worldwide. 1 It consists of a histopathological spectrum that encompasses …
[HTML][HTML] Disease progression modeling for economic evaluation in nonalcoholic fatty liver disease—a systematic review
L Gruneau, M Ekstedt, S Kechagias… - Clinical Gastroenterology …, 2023 - Elsevier
Abstract Background & Aims Globally, 25% of people have Non-Alcoholic Fatty Liver
Disease (NAFLD) and currently there are no approved pharmacological treatments for …
Disease (NAFLD) and currently there are no approved pharmacological treatments for …